Free shipping on all orders over $ 500

 About 1 result found for searched term "2348469-43-0" (0.128 seconds)

Cat.No.  Name Target
M25085 Geptanolimab PD-1/PD-L1
APL-501; CBT-501; GB-226
Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1). Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research of cancer.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.